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Abstract
This study was conducted to evaluate the effects of both exogenous melatonin 
and melatonin receptor antagonist luzindole on the activities of antioxidant en-
zymes (AOE) (superoxide dismutase, SOD; catalase, CAT) and the level of low-
molecular antioxidant vitamins (retinol, α-tocopherol) in male Wistar rats kept 
in normal light conditions (LD 12:12) or constant darkness (DD). In LD, while 
melatonin had no influence on the studied antioxidants, luzindole caused an in-
crease in retinol and a decrease in α-tocopherol contents in the liver compared 
to the control. In DD, with no influence on AOE activities, both drugs exerted 
similar effects on the liver retinol and kidney α-tocopherol contents, increasing 
them in comparison with control. Exposing the animals to DD induced an in-
crease in kidney SOD activity and in liver retinol content. Moreover, DD-mel rats 
had higher SOD activity in the liver and kidney and a higher retinol level in the 
liver compared to LD-mel ones; DD-luz rats had a higher liver retinol content 
compared to LD-luz ones. Liver retinol level seems to be the most sensitive to 
influence of DD, melatonin and luzindole; the data are probably connected with 
the involvement of vitamin A in the regulation of circadian rhythms.
Keywords: constant darkness, melatonin, luzindole, antioxidant enzymes, reti-
nol, α-tocopherol.
List of abbreviations
AOE — antioxidant enzymes;
ATRA — all-trans-retinoic acid;
CAT — catalase;
DD — constant darkness, 24 hours dark;
GPx — glutathione peroxidase;
HPLC — high performance liquid chromatography;
LD — normal light conditions, 12 hours light : 12 hours dark; 
LD (DD)-control — group of rats received placebo;
LD (DD)-mel — group of rats received melatonin;
LD (DD)-luz — group of rats received luzindole;
MT1 and MT2 — melatonin receptors;
ROS — reactive oxygen species;
RZR/RORα and 
NR1F2 (RZR/RORβ) — nuclear orphan receptors;
SCN — suprachiasmatic nucleus;
SOD — superoxide dismutase;
U — enzyme activity unit.
Citation: Kalinina, S., Ilyukha, V., 
Khizhkin, E., Baishnikova, I., Antonova, E., 
and Morozov, A. 2019. Constant darkness 
conditions modulate the effects of 
melatonin and luzindole on the antioxidant 
enzyme activities and levels of retinol 
and α-tocopherol in rats. Bio. Comm. 
64(3): 211–218. https://doi.org/10.21638/
spbu03.2019.305
Author’s information: Svetlana Kalinina, 
PhD, Head of Laboratory, orcid.org/0000-
0003-1906-092X; Viktor Ilyukha, Dr. of Sci. in 
Biology, Director of Institute, orcid.org/0000-
0002-7085-4154; Evgeniy Khizhkin, PhD, 
Senior Researcher, orcid.org/0000-0001-
7831-8025; Irina Baishnikova, PhD, Senior 
Researcher, orcid.org/0000-0001-5064-3731; 
Ekaterina Antonova, PhD, Researcher, orcid.
org/0000-0002-4740-2141; Artem Morozov, 
Assistant, orcid.org/0000-0001-7840-939X
Manuscript Editor: Michael Firsov, 
Sechenov Institute of Evolutionary 
Physiology and Biochemistry, Russian 
Academy of Sciences, Saint Petersburg, 
Russia
Received: March 20, 2019; 
Revised: June 18, 2019; 
Accepted: June 21, 2019; 
Copyright: © 2019 Kalinina et al. This is an 
open-access article distributed under the 
terms of the License Agreement with Saint 
Petersburg State University, which permits 
to the authors unrestricted distribution, and 
self-archiving free of charge.
Funding: The study was carried out under 
the state order (project № 0218-2019-0073).
Competing interests: The authors have 
declared that no competing interests exist.
212 BIOLOGICAL  COMMUNICATIONS,  vol. 64,  issue 3,  July–September,  2019 | https://doi.org/10.21638/spbu03.2019.305
Introduction
Cellular antioxidant responses are crucial for both redox 
signaling and redox damage. Antioxidant molecules are 
able to react with free radicals and oxidant species which 
may behave as deleterious and toxic products, involved 
in the dysfunction of cells and tissues (Espinoza-Diez et 
al., 2015). The part of the cellular defense against oxida-
tive stress is such antioxidant enzymes (AOE) as super-
oxide dismutases (SOD, EC 1.15.1.1), which catalyze the 
dismutation of the extremely toxic superoxide radical 
into potentially less toxic hydrogen peroxide; catalase 
(CAT, EC 1.11.1.6), which stops the formation of the hy-
droxyl radical by converting hydrogen peroxide to oxy-
gen and water; and glutathione peroxidase (GPx), which 
metabolizes hydrogen peroxide and lipid hydroperox-
ides, etc. Among low molecular-weight antioxidants, the 
lipid-soluble substances such as retinol (one of the ma-
jor forms of vitamin A) and α-tocopherol (the main and 
most active component of vitamin E) also act as direct 
scavengers of reactive oxygen species (ROS). Besides the 
lipoperoxyl radical-scavenging activity of retinol, it is an 
essential micronutrient for several biological processes, 
including vision, embryonic development, cell differen-
tiation, growth and development, and regulation of the 
immune system (Owusu and Ross, 2016). α-Tocopherol 
localizes mainly at cell membranes and suppresses the 
formation of lipid hydroperoxides. 
These enzymatic and nonenzymatic antioxidants 
are necessary for sustaining life by maintaining a deli-
cate intracellular redox balance and minimizing unde-
sirable cellular damage caused by ROS (Espinoza-Diez 
et al., 2015). Besides the regulation of antioxidants by 
the redox status of the cell, evidence for their hormonal 
modulation also exists, and the study of such regulation 
becomes very important for physiological and therapeu-
tic approaches (Feingold, Longhurst and Colby, 1993; 
Bolzan, Brown, Goya and Bianchi, 1995; Mayo et al., 
2002; Fernández et al., 2005).
It is well known that AOE activities exhibit an en-
dogenous rhythm with a nighttime rise under normal 
light/dark (LD) conditions that is considered to be cor-
related with physiological melatonin levels (Benot et 
al., 1998; Albarrán et al., 2001; Mayo et al., 2002). It re-
mains unclear whether circadian rhythms of retinol and 
α-tocopherol exist in tissues. In human blood plasma the 
daily changes of retinol and α-tocopherol are negligible 
(Nierenberg and Stukel, 1987). However, the synthesis 
and signaling of all-trans-retinoic acid (ATRA), an ac-
tive metabolite of retinol, exhibit diurnal changes in the 
pineal gland (Ashton, Stoney, Ransom and McCaffery, 
2018).
Melatonin (N-acetyl-5-methoxytryptamine) is the 
pineal hormone, which is produced and secreted with a 
circadian rhythm (low level during the day, or in light, 
and peak values at night, or in darkness) (Tapia-Osorio, 
Salgado-Delgado, Angeles-Castellanos and Escobar, 
2013). Chronobiotic effects of melatonin, modulation of 
sleep processes and influences on bone growth and os-
teoporosis are mediated through the interaction of mel-
atonin with at least two G-protein coupled membrane-
bound melatonin receptors MT1 and MT2 or indirectly 
with nuclear orphan receptors (namely, RZR/RORα and 
NR1F2 (RZR/RORβ)) (Dubocovich et al., 1998; Dubo-
covich, Rivera-Bermudez, Gerdin and Masana, 2003).
Besides such well-known functions of melatonin as 
its involvement in circadian rhythm regulation and in the 
modulation of a variety of neural and endocrine func-
tions, it also acts as the most powerful antioxidant. Due 
to the fact that melatonin can readily pass through cell 
membranes and has access to all sub-cellular organelles, 
this indoleamine and its metabolic derivates are able to 
function as free radical scavengers (at high concentra-
tions) by receptor-independent pathway (Tan et al., 2015). 
Also, melatonin can induce the gene expression and the 
activities of AOE (at physiological concentrations and un-
der non-oxidative conditions), and this ability is receptor-
mediated (Antolín et al., 1996; Kotler et al., 1998; Liu and 
Ng, 2000; Mayo et al., 2002) through RORα (Fang et al., 
2019) and MT1 (Barberino et al., 2017). However, it is not 
fully elucidated whether melatonin might affect not only 
the enzymatic antioxidants but also the level of low mo-
lecular-weight ones such as retinol and α-tocopherol. Pre-
viously (Sergina et al., 2013) we have noted the increase in 
the level of both these substances in the kidney and heart 
of raccoon dogs (Nyctereutes procyonoides, Carnivora, 
Mammalia) treated with a subcutaneous continuous-re-
lease melatonin implant.
To study the receptor-mediated actions of melato-
nin, the melatonin receptor antagonist luzindole (2-ben-
zyl-N-acetyltryptamine) is widely used — it is consid-
ered a non-selective ligand, although it has a 15- to 25-
fold higher affinity for the MT2 melatonin receptor as 
compared to the MT1 receptor (Dubocovich et al., 1998). 
It was shown that luzindole blocks melatonin-mediated 
phase advances of circadian rhythms (Dubocovich et 
al., 1998), exerts antidepressant-like effects in the C3H/
HeN mouse (Dubocovich, Mogilnicka and Areso, 1990), 
exhibits antioxidant actions in vitro (Mathes, Wolf and 
Rensing, 2008) and reduces the level of lipid peroxida-
tion in vitro (Requintina and Oxenkrug, 2007). More-
over, luzindole does not block the antioxidant effects of 
melatonin (Behan, McDonald, Darlington and Stone, 
1999). It remains unclear whether luzindole acts as an 
antioxidant in vivo and whether it influences the level of 
antioxidants. 
Although it is generally known that constant con-
ditions (light or darkness) strongly influence circadian 
rhythmicity and melatonin secretion (Tapia-Osorio, 
Salgado-Delgado, Angeles-Castellanos and Escobar, 







2013), little information is available concerning changes 
in antioxidant level of mammals following darkness ex-
posure (Delibas, Tuzmen, Yonden and Altuntas, 2002; 
Pang et al., 2008). Moreover, it is not known whether 
the altered lighting conditions — for example, constant 
darkness (DD) — can affect the potent antioxidant ef-
fects of melatonin and luzindole in vivo. Exposure of 
mammals to continuous light (LL) or DD chronically at-
tenuates internal 24-hr rhythms, leading to detrimental 
effects on multiple biological processes. In DD the circa-
dian rhythm of melatonin persists, but it is determined 
to be free-running as a result of a steady expansion of 
its secretion durations, while LL rats show an arryhtmic 
temporal pattern (Tapia-Osorio, Salgado-Delgado, An-
geles-Castellanos and Escobar, 2013). In LD 12:12 con-
ditions the melatonin receptor density in the suprachi-
asmatic nucleus (SCN) was shown to be specifically re-
duced during the night, while in DD it did not show any 
variation throughout the 24 h subjective day and night 
(Gauer, Masson-Pevet, Stehle and Pevet, 1994).
The aim of this study was to evaluate the effects of 
both exogenous melatonin and melatonin receptor an-
tagonist luzindole on the activities of AOE (SOD, CAT) 
as well as retinol and α-tocopherol levels in rats exposed 
to LD 12:12 or DD conditions.
Materials and methods
ETHICAL PROCEDURES 
The research was carried out using the equipment of the 
Core Facility of the Karelian Research Centre of the Rus-
sian Academy of Sciences and according to EU Direc-
tive 2010/63/EU for animal experiments with the special 
permission of the Local Ethics Committee of the Insti-
tute of Biology. All efforts were made to minimize the 
number of animals and their suffering.
SUBJECTS AND EXPERIMENTAL DESIGN
Seven-month-old male Wistar rats weighing 450–500 g 
were housed at constant temperature (23  ± 1 °C) with 
laboratory food and water ad libitum. Animals were syn-
chronized for 14  days to a 12:12  light/dark cycle (LD, 
lights on at 07:00, light intensity of 200 lx). After that, a 
portion of the rats was kept under LD conditions, while 
another portion was exposed to constant darkness (DD) 
beginning at the time of lights off for 14  days. Then, 
rats kept under either LD or DD conditions were ran-
domly divided into three groups (n=3–6 in each group): 
LD (DD)-control (received placebo); LD (DD)-mel 
(received melatonin), and LD (DD)-luz (received luz-
indole). After 14  days the rats were terminated by de-
capitation at 10.00 after anesthesia with ether. All treat-
ments of the DD rats were performed under a dim red 
light (640–700 nm, <2 lx) within 3 min. 
DRUGS AND DOSES
The drugs used were melatonin (N-acetyl-5-methoxy-
tryptamine) (Sigma, USA) and melatonin receptor antag-
onist luzindole (2-benzyl-N-acetyltryptamine) (Bachem 
AG, Switzerland). For each drug, 10 mg were dissolved in 
a minimal amount of 95 % ethanol and further diluted to 
100 ml distilled water to yield stock solution, which was 
then diluted in 1 liter tap water (final ethanol concentra-
tion< 0.1 %). The dose of both melatonin and luzindole 
was 0.22 mg/kg BW of rat. Control rats received tap water 
containing 0.0001 % ethanol. All drugs were given to the 
rats with drinking water at night for 14 days. The last ad-
ministration of drugs was given the day before death.
TISSUE COLLECTION
After decapitation, the liver and kidney samples were 
immediately placed on ice for transportation to the lab-
oratory, where samples were stored at –80 °C awaiting 
analyses. All samples were analyzed in triplicate. 
DETERMINATION OF ANTIOXIDANT ENZYMES ACTIVITIES 
AND CONTENTS OF RETINOL AND Α-TOCOPHEROL
Antioxidant enzyme activities 
For determination of AOE activities, tissue samples were 
homogenized in 0.05 M phosphate buffer, pH 7.0, and 
centrifuged at 6000 × g for 15 min. 
Superoxide dismutase (EC 1.15.1.1)
The total SOD activity was measured by the adreno-
chrome method based on the spontaneous autoxidation 
of epinephrine with the formation of product with an 
absorbance peak at 480 nm (Misra and Fridovich, 1972). 
This reaction depends on the presence of superoxide an-
ions and is specifically inhibited by SOD. The amount of 
enzyme that caused 50 % inhibition of epinephrine au-
toxidation is defined as 1 unit (U). SOD activity was ex-
pressed as U per mg protein after normalization with esti-
mated total protein in milligrams in the respective tissues.
Catalase (EC 1.11.1.6)
CAT activity was evaluated by measuring the decrease in 
H2O2 concentration at 240 nm (Bears and Sizes, 1952). 
One enzyme unit (U) is defined as the amount of CAT 
capable of transforming 1.0 µmol of H2O2 for a minute. 
CAT activity was expressed as U per mg protein after 
normalization with estimated total protein in milligrams 
in the respective tissues.
Total protein assay
Results for AOE activities were standardized to total sol-
uble protein content in tissue homogenates. Total tissue 
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protein content was determined by the method of Lowry 
et al. (1951) using bovine serum albumin as standard.
Retinol and α-tocopherol levels
The contents of retinol and α-tocopherol in the tissues 
were determined by HPLC. Proteins in the samples were 
precipitated by ethanol. Retinol and α-tocopherol were 
extracted by n-hexane. Chromatographic separation 
was carried out by microcolumn chromatography with 
a UV detector with n-hexane and isopropanol as an elu-
ent (98.5:1.5). The eluate was monitored at 292 nm for 
α-tocopherol and 324 nm for retinol, and the substances 
were identified by retention time compared with pure 
standards (MP Biomedicals, USA).
STATISTICAL ANALYSIS
All the collected and calculated numerical data were 
transformed into SI units and processed statistically as 
mean ± standard error of the mean. Statistical analy-
sis was done using the Kruskal–Wallis analysis of vari-
ance with the Mann–Whitney U post hoc testing as ap-
propriate. A p-value of <0.05 was taken as significant. 
Relationships between light conditions, drugs and 
studied values were analyzed by means of the Pear-
son’s and Spearman’s correlation coefficients. The sta-
tistical analyses were performed using Sigma-Stat 2.03 
(SPSS Science Software Ltd., USA), while figures were 
prepared using Grapher 7.0 (Golden Software Inc., 
USA).
Fig. 1. The activity of SOD in both melatonin- and luzindole-treated 
rats, exposed to either normal light conditions 12:12 (LD) or constant 
darkness (DD). Results (in U/ mg protein) are expressed as mean ± 
SEM. Significant difference with: ◊ LD-control, * LD-mel rats (p<0.05, 
Kruskall-Wallis test).
Fig. 2. The activity of CAT in both melatonin- and luzindole-treated 
rats, exposed to either normal light conditions 12:12 (LD) or constant 
darkness (DD). Results (in U/ mg protein) are expressed as mean ± 
SEM. * Significant difference with LD-mel rats (p<0.05, Kruskall-Wallis 
test).
Fig. 3. The retinol content in both melatonin- and luzindole-treated 
rats, exposed to either normal light conditions 12:12 (LD) or constant 
darkness (DD). Results (in µg/g wet tissue) are expressed as mean ± 
SEM. Significant difference with: ◊ LD-control, ♦ DD-control, * LD-mel, 
♯ LD-luz rats (p<0.05, Kruskall-Wallis test). 
Fig. 4. The α-tocopherol content in both melatonin- and luzindole-
treated rats, exposed to either normal light conditions 12:12 (LD) or 
constant darkness (DD). Results (in µg/g wet tissue) are expressed as 
mean ± SEM. Significant difference with: ◊ LD-control, ♦ DD-control 
rats (p<0.05, Kruskall-Wallis test).








INFLUENCE OF DD CONDITIONS ON  
STUDIED PARAMETERS
Results of the study are presented in Figures 1–4. DD-
control rats had higher kidney SOD activity (Fig. 1) and 
higher liver retinol content (Fig. 3)  than LD-control 
ones. No significant differences in liver SOD activity, in 
both liver and kidney CAT activities, in kidney retinol 
level and in both liver and kidney α-tocopherol con-
tents were found between LD- and DD-control groups 
(Figs. 1–4). 
INFLUENCE OF BOTH MELATONIN AND  
LUZINDOLE ON STUDIED PARAMETERS IN  
RATS EXPOSED TO LD CONDITIONS
No influence of melatonin on studied antioxidants in 
LD-rats was observed in our study (Figs. 1–4). Treat-
ment of the LD-rats with luzindole had no effect on AOE 
activities but caused an increase in retinol and a decrease 
in α-tocopherol contents in the liver in comparison with 
the control (Figs. 3, 4). Also LD-luz rats had higher kid-
ney AOE activities and higher liver retinol content than 
LD-mel ones (Figs. 1–3).
INFLUENCE OF BOTH MELATONIN AND  
LUZINDOLE ON STUDIED PARAMETERS IN  
RATS EXPOSED TO DD CONDITIONS
In DD-rats, along with having no effect on AOE activi-
ties, both melatonin and luzindole induced an increase in 
the liver retinol content and in the kidney α-tocopherol 
level compared with DD-control (Figs. 1–4).
INFLUENCE OF DD CONDITIONS ON STUDIED 
PARAMETERS IN RATS TREATED WITH MELATONIN AND 
LUZINDOLE
DD-mel rats had higher SOD activities in the liver and 
kidney and a higher retinol level in the liver compared to 
LD-mel ones (Figs. 1, 3). DD-luz rats had a higher liver 
retinol content compared to LD-luz ones (Fig. 3). 
CORRELATIONS
Table 1 shows correlation coefficients between light con-
ditions, drugs, and studied parameters. Only significant 
correlations are presented. The results are mostly similar 
for the Pearson and Spearman coefficients. Most coef-
ficients of correlation were positive. The highest corre-
lation (positive) occurred between liver retinol content 
and light conditions (Pearson: r=0.88; Spearman: r=0.84; 
p=0.000). No correlations were observed between the 
drugs and AOE activity, nor between either light condi-
tions or drug and CAT activity. 
Discussion
The significance of melatonin and melatonin receptor 
antagonist luzindole in the regulation of AOE activities 
and retinol and α-tocopherol levels in Wistar rats was 
evaluated through studies on the effects of exogenously 
administered drugs during rat exposure to normal light 
conditions (LD 12:12) or constant darkness (DD). 
In DD conditions the clock gene expression in the 
SCN does not show a 24-h rhythmicity because the 
clock is not entrained to the environmental lighting cy-
cle (Okamura et al., 1999). Although a circadian rhythm 
of melatonin with higher values during the subjective 
night and lower values during the subjective day persists 
in DD, a smoothing of the melatonin secretion rhythm 
per day is observed—the day portion slightly increases 
and the night portion slightly decreases in comparison 
with the LD regime, but the total concentration of the 
hormone per day in DD does not exceed that in LD 
(Tapia-Osorio, Salgado-Delgado, Angeles-Castellanos 
and Escobar, 2013). 
Little information is available concerning the lev-
els of tissue antioxidants following darkness exposure 
Table 1. Correlations and significance levels (p) in rats 
between light conditions, drugs, and studied values
Parameter correlation
Pearson Spearman
r p r p
Liver retinol level — light 
conditions
0.88 0.000 0.84 0.000
Liver retinol level — liver 
SOD activity
0.62 0.001 0.56 0.007
Liver SOD activity — liver 
CAT activity
0.53 0.008 0.46 0.027
Liver SOD activity — light 
conditions
0.62 0.001 0.62 0.003
Kidney SOD activity — light 
conditions
0.56 0.005 0.52 0.013
Kidney α-tocopherol 
level — drug 
0.60 0.002 0.61 0.003
Liver α-tocopherol level — 
drug 
–0.43 0.036 –0.44 0.034
Kidney retinol level — 
kidney α-tocopherol level
0.49 0.016
Liver retinol level — liver 
α-tocopherol level
–0.43 0.034
Kidney retinol level — light 
conditions
0.42 0.042
Liver retinol level — kidney 
α-tocopherol level
0.42 0.047
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(Delibas, Tuzmen, Yonden and Altuntas, 2002; Pang et 
al., 2008). It is well known that under normal LD con-
ditions the AOE activities exhibit endogenous rhythms 
with a nighttime rise that is considered to be correlated 
with physiological melatonin levels (Benot et al., 1998; 
Albarrán et al., 2001; Mayo et al., 2002). In DD the cir-
cadian rhythm of melatonin is determined to be free-
running, therefore in DD conditions, circadian rhythms 
of AOE activities could differ from those in a normal LD 
cycle. We have noted the higher kidney SOD activity in 
DD-control rats compared to LD-control ones. This is 
in accordance with earlier observations by Delibas N. et 
al. (2002), the increase in SOD and GPx activities in the 
hippocampus of rats exposed to DD in comparison with 
control ones.
Although the SOD activity was shown to be higher 
in the kidneys of DD-control rats in comparison with 
LD-control ones, the activity of another studied en-
zyme — CAT — did not change. The balance between 
the activities of SOD and CAT is necessary to provide 
adequate antioxidant protection. The increase in SOD 
activity, which dismutates the superoxide anion, causes 
an increase in the hydrogen peroxide concentration, 
which if not sufficiently removed by CAT or GPx (not 
determined in our study) will produce hydroxyl radicals 
that are highly toxic for the cell (Antolín et al., 1996). 
However, although the imbalance between the antioxi-
dant enzymes may cause cell injury (Toborek, Kopiecz-
na-Grzebieniak, Drózdz and Wieczorek, 1995), the pro-
tective role of SOD is widely accepted even when other 
AOEs do not change (Warner et al., 1993). Moreover, 
SOD seems to be more sensitive to hormonal changes 
(including changes in melatonin level) than CAT or GPx 
(Kotler et al., 1998; Barp et al., 2002).
Previous studies have suggested that melatonin 
could induce the gene expression and the activity of 
AOEs such as SOD, CAT and GPx, and this effect is con-
sidered to be receptor-mediated through MT1 (Barber-
ino et al., 2017) and RORα (Fang et al., 2019). However, 
in our study we did not find a statistically significant ef-
fect of exogenous melatonin on AOE activities in LD-
rats, but DD-mel rats exhibited higher SOD activities 
in the liver and kidney compared to LD-mel ones. This 
illustrates that changes in physiological levels of mela-
tonin are adequate to alter this component of the tissue 
antioxidative defense. Probably it could be due to altera-
tion in circadian rhythms of melatonin and therefore of 
SOD activity in DD conditions. 
We also detected a higher liver retinol content in 
DD-control rats compared to LD-control ones. The liver 
is known to play an important role in vitamin A ho-
meostasis, because in this organ retinol can follow sev-
eral metabolic pathways, including oxidation to ATRA 
(Wolf, 2001). When the plasma concentration of ATRA 
is increased, there is an accompanying reduction of cir-
culating levels of retinol, suggesting that ATRA may 
have a regulatory effect on retinol metabolism in vivo 
(Wang, Krinsky and Russell, 1993). The DD conditions 
may influence the homeostasis of vitamin A by decreas-
ing circulatory levels of ATRA, as was shown in mice 
(Pang et al., 2008) and increasing liver retinol content, 
as was observed in rats in our study. 
Although data on the melatonin influence on the 
levels of retinol and α-tocopherol in tissues are lack-
ing in the literature, the protective effect of melatonin 
against oxidative stress related to restoration of retinol 
availability was shown in rats treated with melatonin af-
ter heroin administration (Cemek et al., 2011). Besides 
that, melatonin at various concentrations combined 
with α-tocopherol decreases lipid peroxidation in hu-
man placental mitochondria with the effect being addi-
tive (Milczarek et al., 2010). In our study, in contrast to 
LD conditions, where there was no effect of melatonin 
on the retinol and α-tocopherol contents, in DD mela-
tonin induced an increase in liver retinol content and 
in the kidney α-tocopherol level compared with the 
DD-control. Also, we have noted a higher liver retinol 
content in DD-mel rats compared to LD-mel animals. 
The increase in kidney vitamin E content after mela-
tonin administration observed in our study may be a 
result of α-tocopherol mobilization from adipose and 
other tissues as a consequence of antioxidant metabolic 
adaptation of the organism. Moreover, melatonin may 
recycle several oxidized antioxidants including vitamin 
C, α-tocopherol, glutathione, and NADH, and these an-
tioxidants reportedly also recycle the melatonin neutral 
radical (Tan et al., 2015).
Most studies of luzindole action in the organism re-
volve around it being a melatonin receptor antagonist, 
but others have indicated that luzindole has a function 
of its own — for example, protection of rat retinal pho-
toreceptors from light damage (Sugawara et al., 1998). 
Moreover, luzindole’s antioxidant effect is considered to 
exceed that of melatonin (Oxenkrug and Requintina, 
2005). Unfortunately, data on the antioxidant actions of 
luzindole are scarce in the literature and have been re-
vealed only in vitro (Requintina and Oxenkrug, 2007; 
Mathes, Wolf and Rensing, 2008), therefore it remains 
unclear whether this substance acts as an antioxidant 
in vivo. It was shown that luzindole does not suppress 
the antioxidant effects of melatonin (Behan, McDonald, 
Darlington and Stone, 1999) and in a model of melato-
nin plus luzindole co-administration, radical scaveng-
ing may be far more intense than with melatonin alone, 
but in the experiments where luzindole is usually given 
without melatonin, results may be influenced by its an-
tioxidant properties (Mathes, Wolf and Rensing, 2008). 
As in the case of melatonin, luzindole administra-
tion to LD- and DD-rats had no effect on AOE activi-
ties in comparison with corresponding controls. How-







ever, in LD conditions this drug caused an increase in 
retinol and a decrease in α-tocopherol contents in the 
liver compared to the control group. According to the 
antagonism between retinol and α-tocopherol reported 
previously in the literature (Olivares, Rey, Daza and Lo-
pez-Bote, 2009), this result would be expected. In DD 
conditions luzindole induced an increase in liver reti-
nol content and in the kidney α-tocopherol level com-
pared to the control. Although no significant differences 
in studied values were found between melatonin- and 
luzindole-treated rats in DD, in LD conditions the luz-
indole-treated rats had higher kidney AOE activities and 
a higher liver retinol level than the melatonin-treated 
ones. According to recently published data (Barberino et 
al., 2017; Fang et al., 2019), it could be hypothesized that 
MT2 blocking by luzindole can increase the affinity of 
melatonin to MT1 and potentiate its antioxidant actions.
In conclusion, our results indicate that DD exerts 
influence only on the kidney SOD activity and the liver 
retinol level and in several cases significantly modulates 
the effects of exogenous melatonin and melatonin re-
ceptor antagonist luzindole on the studied antioxidants 
mainly by increasing their activity or content. In the case 
of melatonin, these parameters are the liver and kidney 
SOD activities and liver retinol, and in the case of luz-
indole it is liver retinol content. Probably due to the im-
portant role of ATRA in regulation of circadian rhythms 
(Pang et al., 2008; Sherman et al., 2012), the liver retinol 
level seems to be the most sensitive to the influence of 
DD, melatonin and luzindole. The mechanisms of effects 
of these factors on studied parameters need to be further 
investigated.
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